You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

Oral Targeted Therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COPD Exacerbation, COPD Exacerbation Acute Trial (Titrated Oxygen, Standard Oxygen)

Not yet recruiting
  • COPD Exacerbation
  • COPD Exacerbation Acute
  • Titrated Oxygen
  • Standard Oxygen
  • (no location specified)
Feb 2, 2023

Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)

Not yet recruiting
  • Early-stage Breast Cancer
  • Atezolizumab 1200 mg in 20 ML Injection
  • +5 more
  • Heidelberg, Baden-Wuerttemberg, Germany
    National Center for Tumor Diseases
Sep 13, 2022

SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

Recruiting
  • SLE (Systemic Lupus)
  • +4 more
  • CD19 targeted CAR-T cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Sep 25, 2023

/or PD-1 Inhibitors for Unresectable Intrahepatic

Completed
  • Intrahepatic Cholangiocarcinoma
  • hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 7, 2022

Healthcare Resource Utilization and Costs of Immune Checkpoint

Completed
  • Melanoma
    • East Hanover, New Jersey
      Novartis
    May 12, 2023

    Lung Cancer, EGFR Gene Mutation, EGFR Trial in Charlottesville (Sensus Smartwatch Application, RX Cap, Fitbit Sense)

    Recruiting
    • Lung Cancer
    • +3 more
    • Sensus Smartwatch Application
    • +3 more
    • Charlottesville, Virginia
      University of Virginia
    Aug 26, 2022

    Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)

    Recruiting
    • Recurrent Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Low Dose Radiation Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 30, 2023

    Targeted Therapies in BRAF Positive Metastatic Melanoma in US

    Active, not recruiting
    • Melanoma
    • New York, New York
      Pfizer Investigational Site
    Feb 18, 2022

    Sepsis Trial in Damanhur (targeted antibiotics therapy)

    Recruiting
    • Sepsis
    • targeted antibiotics therapy
    • Damanhūr, Elbehairah, Egypt
      Rehab Hussein Werida
    Aug 11, 2022

    Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)

    Not yet recruiting
    • Colorectal Cancer
    • Chemotherapy Effect
    • GuangZhou, Guangdong, China
      The Sixth Affiliate Hospital of Sun Yat-Sen University
    Apr 3, 2023

    Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • With Positive PSMA Expression at Tumor Sites
    • 177Lu-PSMA-1 (radiopharmaceutical)
    • (no location specified)
    Sep 26, 2023

    Results of Specific Gene Testing and Efficacy of Targeted

    Completed
    • Non Small Cell Lung Cancer
      • Changsha, Hunan, China
        Hunan Cancer hospital
      Mar 27, 2023

      Immune Checkpoint Inhibitor Monotherapy or Combined With

      Not yet recruiting
      • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
      • Immune checkpoint inhibitor
      • Guangzhou, Guangdong, China
        Department of Minimally Invasive and Interventional Radiology, L
      Jan 30, 2023

      Liver Transplantation, Hepatocellular Carcinoma Trial in Guangzhou (FOLFOX-HAIC, Lenvatinib, PD-1 inhibitor)

      Not yet recruiting
      • Liver Transplantation
      • Hepatocellular Carcinoma
      • FOLFOX-HAIC
      • +3 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      Jul 26, 2022

      Relapse Multiple Myeloma, Refractory Multiple Myeloma Trial in Hangzhou (BCMA Targeted CAR T-cells)

      Recruiting
      • Relapse Multiple Myeloma
      • Refractory Multiple Myeloma
      • BCMA Targeted CAR T-cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, Medical College, Zhejiang Univers
      Jun 18, 2022

      REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy

      Not yet recruiting
      • CLL, Relapsed
      • +3 more
        • Clermont-Ferrand, France
        • +7 more
        Nov 16, 2022

        Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

        Recruiting
        • Gastric Cancer
        • +6 more
        • CEA CAR-T cells
        • Nanchang, Jiangxi, China
          The First Affiliated Hospital of Nanchang University
        Aug 23, 2023

        NSCLC Trial (disease self-management application)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • disease self-management application
        • (no location specified)
        Nov 9, 2022

        Adverse Events-related Healthcare Resource Utilization and Costs

        Completed
        • Melanoma
        • East Hanover, New Jersey
          Novartis Pharmaceuticals
        Jan 27, 2023

        Cardiotoxicity, HER2-positive Breast Cancer, Heart Failure Trial in London (Phased withdrawal of heart failure medications)

        Not yet recruiting
        • Cardiotoxicity
        • +3 more
        • Phased withdrawal of heart failure medications
        • London, United Kingdom
        • +1 more
        May 19, 2023

        Pediatric Cancer Trial in Eldoret (Vincristine)

        Recruiting
        • Pediatric Cancer
        • Eldoret, Rift Valley, Kenya
          Moi Teaching and Referral Hospital
        Apr 25, 2023

        Prostate Cancer Trial in Glen Burnie, Omaha, Knoxville (PSMA-Targeted [In-111]-Labeled Trillium Compound, PTI-122)

        Recruiting
        • Prostate Cancer
        • PSMA-Targeted [In-111]-Labeled Trillium Compound
        • PTI-122
        • Glen Burnie, Maryland
        • +2 more
        Mar 21, 2023

        Sleep Disturbance, Inflammation, Quality of Life Trial in Chicago (Targeted Cognitive Behavior Therapy for Insomnia,

        Recruiting
        • Sleep Disturbance
        • +4 more
        • Targeted Cognitive Behavior Therapy for Insomnia
        • Information-Only Control
        • Chicago, Illinois
          Northwestern University Feinberg School of Medicine
        Mar 27, 2023

        Gram-negative Bacteremia Trial (Intravenous Antibiotics, Oral Antibiotics)

        Not yet recruiting
        • Gram-negative Bacteremia
        • Intravenous Antibiotics
        • Oral Antibiotics
        • (no location specified)
        Oct 6, 2023

        Rheumatoid Arthritis, Insufficient Response to Methotrexate or Leflunomide Trial in Strasbourg (Methotrexate + targeted therapy

        Recruiting
        • Rheumatoid Arthritis
        • Insufficient Response to Methotrexate or Leflunomide
        • Methotrexate + targeted therapy administration
        • methotrexate or leflunomide + sulfasalazine + hydroxychloroquine administration
        • Strasbourg, France
          Hôpitaux Universitaires de Strasbourg
        Jul 8, 2022